Related Experiment Video
Updated: Aug 9, 2026
05:37
Partial Lobular Hepatectomy: A Surgical Model for Morphologic Liver Regeneration
Published on: May 31, 2018
Summary
Non-narcotic analgesics like NSAIDs and paracetamol can cause liver damage, though severe cases are rare with normal use. Overdosing on paracetamol is a primary cause of significant liver injury, but N-acetylcysteine can prevent harm.
Area of Science:
- Pharmacology
- Hepatology
- Toxicology
Background:
- Non-narcotic analgesics, including salicylates, NSAIDs, paracetamol (acetaminophen), and pyrazolones, can induce hepatic lesions.
- Clinically significant liver damage is uncommon during normal therapeutic use of these agents.
Purpose of the Study:
- To review the patterns and risk factors associated with liver injury from non-narcotic analgesics.
- To differentiate the hepatotoxicity profiles of various analgesic classes.
Main Methods:
- Literature review of reported cases of analgesic-induced hepatotoxicity.
- Analysis of factors influencing drug-induced liver injury, such as age, sex, dose, and pre-existing conditions.
Main Results:
- Salicylates and NSAIDs may cause reversible liver function abnormalities, particularly in females with collagen diseases; severe reactions resembling Reye's syndrome can occur.
- Paracetamol overdose is a leading cause of acute hepatic necrosis, with a significant risk of liver failure and death if untreated.
- N-acetylcysteine administration within 8-10 hours of paracetamol overdose is highly effective in preventing severe liver damage and mortality.
Conclusions:
- While generally safe at therapeutic doses, non-narcotic analgesics carry risks of hepatotoxicity, with paracetamol overdose being a major concern.
- Risk factors for liver injury vary by drug class and patient characteristics.
- Prompt treatment with N-acetylcysteine is crucial for managing paracetamol-induced liver injury.
Related Concept Videos
01:26Diseases of the Liver and Gallbladder
Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...
01:27Inflammatory Bowel Disease I: Ulcerative Colitis
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
01:26Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug binding...
01:22Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
01:00Drug Toxicity: Overview
Drug toxicity quantifies the harm a compound causes to an organism, varying by dose and potentially impacting whole systems or specific organs like the liver. Toxic reactions may arise from venomous insect or spider bites, with effects ranging from mild symptoms to severe outcomes such as brain damage or death. Common forms of acute poisoning include ethanol intoxication and overdose of pain or fever medications, with substances like GHB and heroin being particularly lethal at doses close to...
01:30Drug toxicity: Drug–Drug Interaction
Drug–drug interactions can precipitate toxicity through multiple mechanisms. Absorption interactions alter how drugs enter the body, exemplified when ranitidine increases the absorption of basic drugs, while cholestyramine decreases the levels of propranolol. Protein binding interactions occur when drugs share the same binding sites on plasma proteins. Drugs like aspirin and warfarin, when bound in excess, can lead to increased free drug concentrations, enhancing the potential for...